| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.12 | 7e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |